Abstract
Aldosterone is a mineralocorticoid hormone that regulates blood pressure and salt/water balance. Increased aldosterone levels are found in states of disturbed energy balance such as the metabolic syndrome. Adipose tissue has been recognized to play a pivotal role in the regulation of energy homeostasis. We investigated direct aldosterone effects on brown adipocyte function. Aldosterone dose-dependently inhibited expression of uncoupling protein-1 (UCP-1) by 30 % (p < 0.01). Furthermore, aldosterone dose-dependently impaired insulin-induced glucose uptake by about 25 % (p < 0.01). On a transcriptional level, mRNA of the proinflammatory adipokines leptin and monocyte chemoattractant protein-1 (MCP-1) was increased by 5,000 % and 40 %, respectively, by aldosterone exposure (p < 0.05). This study demonstrates that aldosterone directly impacts on major adipose functions including stimulation of proinflammatory adipokines.
Key words
Adipose tissue - Metabolic syndrome - Monocyte-chemoattractant protein-1
References
-
1
Isomaa B.
A major health hazard: the metabolic syndrome.
Life Sci.
2003;
73
2395-2411
-
2
Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft F C, Sharma A M.
Weight loss and the renin-angiotensin-aldosterone system.
Hypertension.
2005;
45
356-362
-
3
Lamounier-Zepter V, Bornstein S R, Ehrhart-Bornstein M.
Mechanisms of obesity-related hypertension.
Horm Metab Res.
2004;
36
376-380
-
4
Sharma A M, Engeli S, Pischon T.
New developments in mechanisms of obesity-induced hypertension: role of adipose tissue.
Curr Hypertens Rep.
2001;
3
152-156
-
5
Rajala M W, Scherer P E.
Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis.
Endocrinology.
2003;
144
3765-3773
-
6
Minokoshi Y, Kahn C R, Kahn B B.
Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis.
J Biol Chem.
2003;
278
33 609-33 612
-
7
Cannon B, Nedergaard J.
Brown adipose tissue: function and physiological significance.
Physiol Rev.
2004;
84
277-359
-
8
Krief S, Lonnqvist F, Raimbault S, Baude B, van Spronsen A, Arner P, Strosberg A D, Ricquier D, Emorine L J.
Tissue distribution of beta 3-adrenergic receptor mRNA in man.
J Clin Invest.
1993;
91
344-349
-
9
Yang X, Enerback S, Smith U.
Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance.
Obes Res.
2003;
11
1182-1191
-
10
Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiera F, Sharma A M.
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?.
Int J Biochem Cell Biol.
2003;
35
807-825
-
11
Engeli S, Sharma A M.
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.
J Mol Med.
2001;
79
21-29
-
12
Goossens G H, Blaak E E, van Baak M A.
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.
Obes Rev.
2003;
4
43-55
-
13
Kraus D, Fasshauer M, Klein J.
Neuropeptide and peripheral hormone crosstalk with adipocyte function.
Adipocytes.
2005;
in press
-
14
Klein J, Fasshauer M, Ito M, Lowell B B, Benito M, Kahn C R.
beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes.
J Biol Chem.
1999;
274
34 795-34 802
-
15
Klein J, Fasshauer M, Klein H H, Benito M, Kahn C R.
Novel adipocyte lines from brown fat: a model system for the study of differentiation, energy metabolism, and insulin action.
Bioessays.
2002;
24
382-388
-
16
Pfaffl M W, Horgan G W, Dempfle L.
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.
Nucleic Acids Res.
2002;
30
e36
-
17
Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R.
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes.
Biochem Biophys Res Commun.
2004;
317
598-604
-
18
Friedman J M.
The function of leptin in nutrition, weight, and physiology.
Nutr Rev.
2002;
60
S1-S14; discussion S68 - S84, 85 - 87
-
19
Christiansen T, Richelsen B, Bruun J M.
Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects.
Int J Obes Relat Metab Disord.
2005;
29
146-150
-
20
Sartipy P, Loskutoff D J.
Monocyte chemoattractant protein 1 in obesity and insulin resistance.
Proc Natl Acad Sci U S A.
2003;
100
7265-7270
-
21
Viengchareun S, Penfornis P, Zennaro M C, Lombes M.
Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes.
Am J Physiol Endocrinol Metab.
2001;
280
E640-E649
-
22
Penfornis P, Viengchareun S, Le Menuet D, Cluzeaud F, Zennaro M C, Lombes M.
The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes.
Am J Physiol Endocrinol Metab.
2000;
279
E386-E394
-
23
Kraus D, Fasshauer M, Ott V, Meier B, Jost M, Klein H H, Klein J.
Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes.
J Endocrinol.
2002;
175
185-191
-
24
Buyse M, Viengchareun S, Bado A, Lombes M.
Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes.
FASEB J.
2001;
15
1357-1366
-
25
Kershaw E E, Flier J S.
Adipose tissue as an endocrine organ.
J Clin Endocrinol Metab.
2004;
89
2548-2556
-
26
Torpy D J, Bornstein S R, Taylor W, Tauchnitz R, Gordon R D.
Leptin levels are suppressed in primary aldosteronism.
Horm Metab Res.
1999;
31
533-536
-
27
Haluzik M, Sindelka G, Widimsky J Jr, Prazny M, Zelinka T, Skrha J.
Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity.
J Hum Hypertens.
2002;
16
41-45
-
28
Wisse B E.
The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
J Am Soc Nephrol.
2004;
15
2792-2800
J. Klein, M. D.
Department of Internal Medicine I, University of Lübeck
Ratzeburger Allee 160 · 23538 Lübeck · Germany
Fax: +49 451 500 4193
Email: j.klein@uni-luebeck.de